Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Avenir Wellness Solutions Inc AVRW

Avenir Wellness Solutions, Inc. is a platform technology company. The Company develops proprietary wellness, nutraceutical, and topical delivery systems. The Company is focused on the development of nutraceutical formulation and delivery technologies in novel dosage forms to improve wellness. Its wholly owned subsidiary, The Sera Labs, Inc. (Sera Labs), is engaged the development, production... see more

Recent & Breaking News (OTCQB:AVRW)

CURE Pharmaceutical [OTCQB: CURR] Takes First Step To Secure Hemp CBD Supply Chain by Partnering with Fytiko Farms

GlobeNewswire August 21, 2019

CURE Pharmaceutical Expands Board with Two Women Directors

GlobeNewswire August 7, 2019

CURE Pharmaceutical [OTCQB:CURR] Secures Patent on High Loading of Active Ingredient in Oral Thin Films

GlobeNewswire July 24, 2019

CURE Pharmaceutical [OTCQB:CURR] Secures Patent on Oral Thin Films With Bi-Phasic Release of Natural Ingredients

GlobeNewswire July 16, 2019

CURE Pharmaceutical [OTCQB:CURR] and Canopy Growth to Produce CBD Oral Thin Films

GlobeNewswire June 19, 2019

CURE Pharmaceutical to Present at the 9th Annual LD Micro Invitational

GlobeNewswire May 30, 2019

CURE Pharmaceutical Secures Patent on Oral Thin Film Containing Bioactive Cannabinoid Molecules

GlobeNewswire May 22, 2019

CURE Pharmaceutical Expands Leadership Team with Key New Hires

GlobeNewswire May 20, 2019

CURE Pharmaceutical (OTCQB:CURR) Closes Acquisition Of Privately-Held Chemistry Holdings Inc.

GlobeNewswire May 14, 2019

Meroven LLC and CURE Pharmaceutical Enter Exclusive Marketing and Distribution Agreement for Spee-D for the USA

GlobeNewswire May 2, 2019

CURE Pharmaceutical Extends Closing Of Privately-Held Chemistry Holdings Inc. Acquisition to May 13

GlobeNewswire May 1, 2019

Cure Pharmaceutical [OTCQB:CURR] to Present at the "Planet MicroCap Showcase 2019"

GlobeNewswire April 30, 2019

CURE Pharmaceutical Named "Innovative Business of the Year" By Oxnard Chamber of Commerce

GlobeNewswire April 26, 2019

Uptick Newswire Hosts CURE Pharmaceutical on The Stock Day Podcast to Discuss Major Milestones and 2019 Goals

Accesswire April 16, 2019

United Smart Cities and Cure Pharmaceutical Launch Global Healthcare Awareness Initiative

GlobeNewswire April 9, 2019

CURE Pharmaceutical to Acquire Privately-Held Chemistry Holdings Inc., Expanding Its Technology Platform in Oral Drug Delivery

GlobeNewswire April 1, 2019

CURE Pharmaceutical Announces Completion of FDA Pre-IND Review and Clinical Trial Plans for CUREfilm Blue™ for Erectile Dysfunction

GlobeNewswire March 26, 2019

CURE Pharmaceutical Expands U.S. DEA Approval to Manufacture Pharmaceuticals Using Whole Cannabis Plant

GlobeNewswire March 12, 2019

National Healthcare Economics and Policy Expert Ruben Jose King-Shaw Jr Joins CURE Pharmaceutical’s Board of Directors

GlobeNewswire January 29, 2019

CURE Pharmaceutical Appoints Chairman, Adds Member to its Board of Directors

GlobeNewswire January 15, 2019